WALTHAM, Mass. , Jan. 08, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced that it has been named a CES ® 2019 Innovation Awards Honoree for Quell ® 2.0 Wearable Pain Relief Technology™ in the Fitness, Sports and Biotech product category.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® was named Winner in the Wearable Tech category at the 19 th Annual SXSW Interactive Innovation Awards, held last night in Austin, TX. The Wearable Tech award honors "new hardware that revolutionizes
WALTHAM, Mass. , May 03, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that preliminary results from a study of Quell ® wearable pain relief in chronic low back pain will be presented at the 9th World Congress of the World Institute of Pain in Dublin, Ireland May 9-12,
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that researchers from the University of Rochester School of Medicine and Dentistry will present a scientific poster titled "Wearable TENs band for chemotherapy-induced peripheral neuropathy (CIPN): A feasibility
Nipro Diagnostics and NeuroMetrix Announce Diabetes Focused Collaboration for the Retail Medical Clinic Market WALTHAM, Mass. & FT LAUDERDALE, Fla., Jun 15, 2011 (BUSINESS WIRE) -- Nipro Diagnostics, Inc. and NeuroMetrix, Inc. (Nasdaq: NURO) today announced their collaboration to evaluate
WALTHAM, Mass. , May 01, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it will be participating in the 3rd annual Disruptive Growth & Healthcare Conference in New York City on May 8-9, 2018 sponsored by RHK Capital and ReedSmith.
WALTHAM, Mass. , Jan. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (NASDAQ: NURO) will issue its fourth quarter 2018 financial results on Thursday morning January 24, 2019 . A conference call will be held shortly afterwards at 8:00 a.m. Eastern. The call may be accessed in the United States at
WOBURN, Mass. , Oct. 23, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its Q3 2023 business and financial highlights before the opening of the market on October 26, 2023 . The Company will host a conference call at 8:00 a.m., Eastern Time on
WOBURN, Mass. , Oct. 12, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 third quarter financial results before the opening of the market on Oct 20, 2022 . The Company will host a conference call at 8:00 a.m., Eastern Time on Oct 20, 2022 to